Cargando…
Predictive Simulations in Preclinical Oncology to Guide the Translation of Biologics
Preclinical in vivo studies form the cornerstone of drug development and translation, bridging in vitro experiments with first-in-human trials. However, despite the utility of animal models, translation from the bench to bedside remains difficult, particularly for biologics and agents with unique me...
Autores principales: | Dong, Shujun, Nessler, Ian, Kopp, Anna, Rubahamya, Baron, Thurber, Greg M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927291/ https://www.ncbi.nlm.nih.gov/pubmed/35308243 http://dx.doi.org/10.3389/fphar.2022.836925 |
Ejemplares similares
-
Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio Imaging
por: Nessler, Ian, et al.
Publicado: (2020) -
The discovery of rivaroxaban: translating preclinical assessments into clinical practice
por: Kubitza, Dagmar, et al.
Publicado: (2013) -
Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
por: Fisher, Amy S., et al.
Publicado: (2021) -
Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?
por: Nessler, Ian, et al.
Publicado: (2018) -
Generation
of DAR1 Antibody-Drug Conjugates for Ultrapotent
Payloads Using Tailored GlycoConnect Technology
por: de Bever, Laureen, et al.
Publicado: (2023)